Insider Transactions in Q2 2020 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,647
-5.76%
|
$2,267,736
$488.21 P/Share
|
|
Apr 01
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+6.9%
|
$1,632,000
$272.7 P/Share
|
|
Apr 01
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
600
-0.24%
|
$291,600
$486.54 P/Share
|
|
Apr 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$48,600
$486.06 P/Share
|